Top Markets
Coin of the day
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.

Steminent Biotherapeutics Inc.

7729
Rangering i aksjer #18868
Steminent Biotherapeutics Inc. is a biopharmaceutical company dedicated to... Steminent Biotherapeutics Inc. is a biopharmaceutical company dedicated to pioneering novel cellular therapeutics, with a primary focus on the research and development of innovative stem cell drugs. Their flagship product is Stemchymal, which is recognized for its significant therapeutic benefits and broad range of potential applications. The firm was established on December 18, 2007, and operates from its headquarters in Taipei, Taiwan.
Aksjekurs
$2.51
Markedsverdi
$183.34M
Endring (1 dag)
0.90%
Endring (1 år)
91.17%
Land
TW
Handel Steminent Biotherapeutics Inc. (7729)

Kategori

P/S-forhold for Steminent Biotherapeutics Inc. (7729)
P/S-forhold per 2026 TTM: 0
Ifølge Steminent Biotherapeutics Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Steminent Biotherapeutics Inc. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
10.17 -
US
10.13 -
NL
2.95 -
AU
11.28 -
US
- -
CH